Form 4 for AXGN Axogen, Inc.
Accepted 2024-06-06 00:00:00 ET · period of report 2024-06-04 · accession 0000805928-24-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-06 | 2024-06-04 | AXGN | Freitag Gregory Gene | Dir | M - OptEx | $0.00 | +11.9K | 283.5K | +4% | $0 |
| D | 2024-06-06 | 2024-06-04 | AXGN | Freitag Gregory Gene | Dir | M - OptEx | $0.00 | -11.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-04 | M | A | 11,904 | $0.00 | 283,498 | D | — | — | (F1) Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding and unvested equity totaling 11, 904 shares of common stock. |
| 2 | Derivative | Restricted Stock Units | 2024-06-04 | M | D | 11,904 | $0.00 | 0 | D | — · — to — | 11,904 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F1) Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding and unvested equity totaling 11, 904 shares of common stock. |